Modeling of fusion inhibitor treatment of RSV in African green monkeys
From MaRDI portal
Publication:1714364
DOI10.1016/j.jtbi.2018.07.029zbMath1406.92352OpenAlexW2884066489WikidataQ59355948 ScholiaQ59355948MaRDI QIDQ1714364
Gilberto González-Parra, Hana M. Dobrovolny
Publication date: 31 January 2019
Published in: Journal of Theoretical Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.jtbi.2018.07.029
Related Items
The role of syncytia during viral infections ⋮ The rate of viral transfer between upper and lower respiratory tracts determines RSV illness duration ⋮ Use of mathematical modelling to assess respiratory syncytial virus epidemiology and interventions: a literature review
Cites Work
- Assessing uncertainty in A2 respiratory syncytial virus viral dynamics
- Mathematical models for immunology: current state of the art and future research directions
- An accurate two-phase approximate solution to an acute viral infection model
- Modeling amantadine treatment of influenza A virus in vitro
- Neuraminidase inhibitors for treatment of human and avian strain influenza: a comparative modeling study
- Modelling the effects of adherence to the HIV fusion inhibitor enfuvirtide
- On Identifiability of Nonlinear ODE Models and Applications in Viral Dynamics
- Determining drug efficacy parameters for mathematical models of influenza
- Model Selection and Multimodel Inference
